Transdermal nanocarriers in 2026: overview
Transdermal nanocarriers are nanoscale systems designed to move drugs into or across the skin. They can help address the stratum corneum, the skin’s main barrier to many therapeutic compounds, and may support local treatment or delivery into systemic circulation. Lipid, vesicular, polymeric and emulsion-based systems offer different ways to carry and release drugs, but performance depends on formulation, skin penetration, stability and safety.
Recent work is pairing carriers with methods that alter or bypass the skin barrier. In September 2026, Universiti Sains Malaysia researchers used 3D-printed microfluidic chips to investigate scalable nanoemulsion preparation, while Integral University reported optimized berberine-loaded nanostructured lipid carriers with in vitro and in vivo evaluation. A September study from Jinan University and collaborators examined how nanoparticle size affects the fate of carriers in dissolving microneedles. Other work combines lipid carriers with CO₂ laser-mediated delivery for skin and hair-follicle targeting. These directions point toward hybrid delivery systems and more controlled formulation and deposition.
- 1Carriers meet devices: Studies combining nanocarriers with dissolving microneedles and laser-mediated delivery aim to address the skin barrier through complementary mechanisms.
- 2Lipid systems gain ground: Lipid matrix nanoparticle activity grew 34.8%, with recent work spanning berberine delivery, wound infection and localized treatment.
- 3Research outpaces patents: Publications grew 28.4% in the latest year while patent activity declined 50.4%, a divergence that makes translation and protectable formulation advances worth watching.
Top organizations working on transdermal nanocarriers
Ranked by Linknovate activity score · last 24 monthsThe activity score adds up the relevance of every patent, publication, grant and news item linking an organization to transdermal nanocarriers. Showing 7 of 1,085 organizations.
| # | Organization | Approach | Signals (24 mo) | Momentum | Why it matters |
|---|---|---|---|---|---|
| 1 | 
Chitkara University
Research · India |
Vesicular carriers | PUB 40 | +108% | Researchers affiliated with the university review vesicular nanocarriers for topical and transdermal antibiotic delivery, alongside nanocarrier strategies for dermatological applications. |
| 2 | 
King Khalid University
Research · Saudi Arabia |
Vesicular carriers | PUB 36 | +250% | Recently, researchers affiliated with the university investigated selegiline-loaded cationic liposomes delivered with microneedles for transdermal treatment, and have also studied ethosomal skin delivery. |
| 3 | 
Prince Sattam bin Abdulaziz University
Research · Saudi Arabia |
Vesicular carriers | PUB 33 | +36% | Recently, researchers affiliated with the university developed a sterosome-based miconazole nanocarrier for cutaneous candidiasis; related work combines lipid nanocarriers with laser-mediated skin delivery. |
| 4 | IC
ISF College of Pharmacy & Research
Research · India |
General | PUB 20 | -46% | Researchers affiliated with the college review nanocarrier formulation strategies for psoriasis therapy and their potential in topical treatment. |
| 5 | 
Cairo University
Research · Egypt |
Vesicular carriers | PUB 33 | +460% | Recently, researchers affiliated with the university studied sterosome-based miconazole delivery and engineered phytosomal carriers for skin localization; other work explores lipid nanoparticles for topical applications. |
| 6 | JH
Jamia Hamdard University
Research · India |
Lipid matrix nanoparticles | PUB 26 | +0% | Researchers affiliated with the university study nanostructured lipid carriers for drug targeting and review ethosomes for delivering plant-derived compounds to skin. |
| 7 | CP
College Pharmacy
Research |
Vesicular carriers | PUB 30 | -24% | Researchers affiliated with the college review transferosomes for transdermal delivery and lipid carriers for potential rheumatoid arthritis treatment. |
| 8 | ··Hidden organizationCompany | Approach | PAT 00 · PUB 00 GRANTS 0 · NEWS 00 | +00% | Available to registered users. |
| 9 | ··Hidden organizationCompany | Approach | PAT 00 · PUB 00 GRANTS 0 · NEWS 00 | +00% | Available to registered users. |
| 10 | ··Hidden organizationCompany | Approach | PAT 00 · PUB 00 GRANTS 0 · NEWS 00 | +00% | Available to registered users. |
Startups to watch and leading research centers
Startups to watch 14 total
- SSShenzhen Shinehigh Innovation Technology Co., Ltd.ChinaRecently, the company was associated with research on a cationic ionic-liquid–liposome platform for transdermal delivery of antisense RNA targeting androgen-dependent skin disorders.
JUVIC, Inc.South KoreaThe company develops microneedle delivery technology; a research study examined delivery of an mRNA–liposome vaccine through dissolving microneedles.- GSGd Shinesky Medical Supplies Health Technology Co., Ltd.ChinaRecently, the company was associated with research on a transdermal delivery system using self-assembled polypeptides for skin anti-aging applications.
- ··Hidden startupCountryAvailable to registered users, with funding and founding year.
- ··Hidden startupCountryAvailable to registered users, with funding and founding year.
Leading research institutions 958 total
- Chitkara UniversityIndiaResearchers affiliated with the university review vesicular nanocarriers for topical and transdermal antibiotic delivery, alongside nanocarrier strategies for dermatological applications.
- King Khalid UniversitySaudi ArabiaRecently, researchers affiliated with the university investigated selegiline-loaded cationic liposomes delivered with microneedles for transdermal treatment, and have also studied ethosomal skin delivery.
- Prince Sattam bin Abdulaziz UniversitySaudi ArabiaRecently, researchers affiliated with the university developed a sterosome-based miconazole nanocarrier for cutaneous candidiasis; related work combines lipid nanocarriers with laser-mediated skin delivery.
- ··Hidden research institutionCountryAvailable to registered users, with their key researchers.
- ··Hidden research institutionCountryAvailable to registered users, with their key researchers.
Where transdermal nanocarriers innovation happens
Share of documents with at least one organization from each country.
Open the interactive map with all 1,085 organizationsMain technical approaches
Last 24 months| Approach | What it is | Documents | Leading organizations |
|---|---|---|---|
| Vesicular carriers | Liposomes, ethosomes and related vesicles carry drugs in membrane structures; their flexibility can aid skin delivery, but formulation stability and penetration remain challenges. | 1,044 |
King Khalid University, Chitkara University, Prince Sattam bin Abdulaziz University |
| Lipid matrix nanoparticles | Solid lipid nanoparticles and nanostructured lipid carriers embed drugs in lipid matrices; they can support skin retention, but loading and release depend on lipid composition. | 317 |
Siksha O Anusandhan (Deemed to be University), Chitkara University, ISF College of Pharmacy & Research |
| Polymeric nanocarriers | Polymer-based particles can be tuned for drug protection and release, but material selection, biocompatibility and skin transport require careful balancing. | 388 |
Quaid-i-Azam University, Siksha O Anusandhan (Deemed to be University), King Khalid University |
| Nanoemulsion carriers | Fine oil-and-water dispersions can solubilize poorly water-soluble compounds, but surfactant choice, stability and scalable preparation are key trade-offs. | 477 |
Chitkara University, Siksha O Anusandhan (Deemed to be University), Jamia Hamdard University |
| Inorganic nanoparticles | Inorganic particles can provide distinctive optical or functional properties, but skin compatibility, persistence and safety need close assessment. | 171 |
Siksha O Anusandhan (Deemed to be University), Insightace Analytic, Meerut Institute of Engineering and Technology |
Emerging trends
Last 12 months vs previous 36 monthsTerms whose frequency in the last 12 months grew the most compared with the previous 36 months.
Funding and investment
Recent funding rounds
The recorded funding totals $6,041,989 across 8 grants since 2020. Three funding rounds total $5,796,629; listed examples include a Stanford University grant from the California Institute for Regenerative Medicine in January 2025 and a University of New South Wales seed round from Luminary Partners in May 2025.
Patent landscape
Top patent holders · last 24 monthsRecent developments
Latest news, duplicates removed- Aug 2026Boston, Aug. 27, 2026 (GLOBE NEWSWIRE) -- The global topical drug delivery market is projected to grow from $222.9 billion in 2025 to $362.3 billion by 2031, at a compound annual growth rate (CAGR) of 8.7% from 2026 to…GlobeNewswire - Market Research Reports
- Aug 2026A mild, surfactant-free coating strategy uses glucan and ethylcellulose shells to curb TiO2 photoreactivity, improve formulation stability, and substantially boost laboratory-measured UVA and UVB protection. Paper…AZoNano.com - Nanotechnology News Feed
- Jun 2026Microneedle Device Customization Services. This modular platform has integrated cutting-edge micro-fabrication equipment, advanced material engineering, and analytical validation systems to help biotechnology companies…Press Release Distribution Service
- May 2026From microneedles to nanocarriers, researchers are rethinking how GLP-1 medicines could become longer-lasting, easier to tolerate, and more patient-friendly, while cautioning that many next-generation systems remain…The Medical News
- Month 20XXHidden developmentAvailable to registered users with alerts enabled.
Frequently asked questions about transdermal nanocarriers
Which transdermal nanocarrier startups are active in 2026?
Three listed startups are Shenzhen Shinehigh Innovation Technology Co., Ltd., JUVIC, Inc. and Gd Shinesky Medical Supplies Health Technology Co., Ltd. Their associated work includes a cationic ionic-liquid–liposome platform for antisense RNA, microneedle delivery, and self-assembled polypeptides for skin applications. These examples indicate different technical directions; the available facts do not establish comparative commercial readiness.
How much funding has transdermal nanocarriers received?
The recorded total is $6,041,989 across 8 grants since 2020, alongside $5,796,629 across 3 funding rounds. The funding-round records include a Stanford University grant of $5,596,629 from the California Institute for Regenerative Medicine in January 2025 and a $200,000 University of New South Wales seed round from Luminary Partners in May 2025.
What were the latest transdermal nanocarriers funding rounds?
The latest listed round is a $200,000 seed round for the University of New South Wales, dated May 2025, with Luminary Partners named as investor. Stanford University also has a grant record dated September 2025 with the National Institutes of Health listed as investor; its amount is not specified. The other Stanford grant is dated January 2025.
Who holds the most transdermal nanocarriers patents?
Fudan University and the Institute Of Chemistry Chinese Academy Of Sciences lead the listed patent holders, with 6 patents each. LIFEACTIVE, INC. follows with 5. Other named holders include Xiamen University, Atai Consulting, BEIJING BENEWILL TECHNOLOGY DEVELOPMENT CO., LTD. and Yubeck, Inc., each with 4 listed patents.
Is transdermal nanocarrier patent activity growing?
No: patent activity declined 50.4% in the defined latest-12-month comparison with the previous 12 months. In contrast, publications grew 28.4% over that period, while overall activity grew 8.4%. This divergence shows stronger recent publication momentum than patent momentum; the figures alone do not establish why the trends differ or indicate commercial readiness.
What are the latest developments in transdermal nanocarriers?
Recent developments include microfluidic nanoemulsion preparation studied by Universiti Sains Malaysia in September 2026 and berberine-loaded nanostructured lipid carriers evaluated by Integral University that same month. A September study from Jinan University and collaborators examined particle-size effects in dissolving microneedles. August 2026 work also investigated lipid carriers combined with CO₂ laser-mediated delivery for skin penetration and hair-follicle targeting.
What are the main approaches in transdermal nanocarriers and how do they differ?
Five approaches are represented: vesicular carriers, lipid matrix nanoparticles, polymeric nanocarriers, nanoemulsion carriers and inorganic nanoparticles. They differ in their carrier structure and how they hold or transport drugs. Vesicles use membrane structures; lipid and polymer systems use matrix or polymer materials; nanoemulsions disperse oil and water; inorganic particles offer distinct material properties. Each approach presents different formulation, stability, skin transport and safety considerations.
Which countries lead transdermal nanocarrier research?
China leads the listed country totals with 1,902 documents, followed by India with 1,827 and the United States with 1,790. Germany has 514 and the United Kingdom has 501. These figures describe document counts in the supplied country data, not the number of companies, research groups or products in each country.
What are the applications of transdermal nanocarriers?
The listed applications are dermatologic treatment, systemic therapy, vaccines and immunization, and cosmetics and skincare. Dermatologic treatment has 565 documents, cosmetics and skincare 208, systemic therapy 165, and vaccines and immunization 150. Recent examples include formulations studied for psoriasis, skin infections, alopecia, and transdermal delivery of medicines intended for systemic use.